News
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China
Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that the National Medical Products Administration (NMPA) of China has granted approval of the company’s monoclonal neutralizing...
Clinical Trials
CASI Pharmaceuticals And Bioinvent Announce CTA Approval For Clinical Study Of BI-1206 In NHL In China
CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Products Administration (NMPA) has approved the Company’s Clinical Trial Application (CTA) for BI-1206, a First-in-class fully...
News
ChargePoint Technology accelerates expansion to enhance services in US market
ChargePoint Technology, the powder containment and aseptic processing specialist, has accelerated its expansion plans in North America by introducing a newly established team to deliver outstanding customer service in the region.
In addition to the company’s existing New Jersey base,...
News
DoKaSch Temperature Solutions strengthens presence in Japan
DoKaSch Temperature Solutions continues to expand its business in Asia. With the dedicated subsidiary DoKaSch Temperature Solutions K.K. in Tokyo and a new service station at Narita International Airport, customers in Japan now have optimal access to the “Opticooler”...
News
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - COVID-19 Pandemic Special...
News
Peli BioThermal Opens India Service Centre
New service centre expands company global footprint in region of key growth in pharma manufacturingand distribution
Peli BioThermal, the global name in temperature controlled packaging solutions, announces the opening of its latest service centre located in India.The new service centre...
Drug Research
Operations commence at Genezen’s lenti- and retroviral vector process development lab
Genezen, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has officially opened its new process development and analytical lab.
The lab will deliver a full...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















